Boston Scientific CEO Mike Mahoney says Farapulse, the company’s pulsed field ablation (PFA) system, is the most transformational product he has seen in his 12-year career with the company. But don’t just take his word for it; one look at the company’s first-quarter earnings solidly backs up the sentiment.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,